Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis (Q43629412)

25 November 2017

title

Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis (English)

1 reference

adaptive radiation therapy

25 November 2017

main subject

0 references

1 reference

Steven E Schild

6

0 references

Dirk Rades

1

object named as

Dirk Rades

1 reference

25 November 2017

Annika Panzner

2

1 reference

25 November 2017

Liesa Dziggel

3

1 reference

25 November 2017

Tiina Haatanen

4

1 reference

25 November 2017

Radka Lohynska

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

13 December 2011

1 reference

25 November 2017

1 reference

25 November 2017

volume

118

1 reference

25 November 2017

issue

15

1 reference

25 November 2017

page(s)

3852-3859

1 reference

Prognosis of patients treated for intracranial metastases with whole-brain irradiation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Dose escalation of whole-brain radiotherapy for brain metastases from melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

The combined use of radiation therapy and lonidamine in the treatment of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26680

7 January 2021

Identifiers

DOI

10.1002/CNCR.26680

1 reference

25 November 2017

1 reference